Early decision and psychosocial support intervention for men with localised prostate cancer: an integrated approach

Abstract

In this setting, a tele-based supportive care and decision support intervention for men newly diagnosed with prostate cancer was feasible. The use of brief screening measures as within-intervention clinical tools appears promising.

Men with prostate cancer over the first year of illness: their experiences as biographical disruption

“…Theories which are mindful of the impact of gender on access to and use of supportive services have taken precedence in some of the literature [3]. Alongside these, a strong strand of research has sought to identify the expressed needs of men, for example, studies validating an instrument to determine needs at different stages through the cancer journey [12] and interventions addressing the need to support men in treatment decision making [32]. Other studies have been future-focused, identifying support needs in employment during and after treatment [34] and measuring quality of life regarding fear of recurrence [16].…”

The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial

“…To address decisional needs, investigators have developed patient education programs, [16–19] nurse coaching telephone interventions [20] or websites [21] to inform men about medical options and facilitate a decision. However, only a few have been evaluated in randomized trials [16,17,20] and none have comprehensively addressed the personal preferences which men bring to the decision.…”

“…However, only a few have been evaluated in randomized trials [16,17,20] and none have comprehensively addressed the personal preferences which men bring to the decision. Furthermore, components of DC have either not been measured, were compared to historical controls only, [19] or, as in Davison’s work, were not found to be significantly different between trial arms, [17] despite being cited by Cochrane reviewers [22] as key attributes with which to evaluate the impact of health treatment decisions for LPC. Thus, the evidence for any decision support system tested in the LPC setting is quite limited with regard to reducing DC.…”

Psychosocial Oncology Supports for Men

“…These interventions have focused on reducing men's distress or enhancing quality of life following a cancer diagnosis through individualized instruction or support from specialists or peers (Badger et al, 2011;Chambers et al, 2008;Chambers et al, 2012;Chambers et al, 2013;Giesler et al, 2005;Livingston et al, 2010;Weber et al, 2004), group education/ discussion (Boonzaier et al, 2009;Lepore et al, 2003;Traeger et al, 2013), expressive writing (Pauley et al, 2011;Rosenberg et al, 2002), and via multidisciplinary approaches integrating dietary, mood management, physical activity, and/ or social support activities (Adamsen et al, 2001;Ames et al, 2011;Berglund et al, 2007;Carmack Taylor et al, 2006;Daubenmier et al, 2006;Kronenwetter et al, 2005). Beyond broad efforts to enhance quality of life, interventions have been designed to bolster men's knowledge about their diagnosis and disease, treatment, and/or sideeffects (Flynn et al, 2004;Hack et al, 2007;Kim et al, 2002;Templeton & Coates, 2004), improve their adaption to cancer (Walsh Scura et al, 2004), facilitate treatment-related decision making (Davison et al, 2007), reduce decision-related distress (Berry et al, 2012;Steginga, Ferguson, Clutton, Gardiner, & Nicol, 2008), and enhance self-management skills and general capacities to support psychological health (Martin et al, 2013).…”

“…Programs have also been designed for men with different stages of prostate cancer, including men in watchful waiting and active surveillance (Bailey et al, 2004;Daubenmier et al, 2006;Kazer et al, 2011), with localized or early stage disease (Canada et al, 2005;Chambers et al, 2008;Chambers et al, 2013;Collins et al, 2013;Davison et al, 2007;Kronenwetter et al, 2005;Mishel et al, 2002;Penedo et al, 2006;Penedo et al, 2007;Steginga et al, 2008;Traeger et al, 2013), men experiencing a biochemical recurrence (Ames et al, 2011), those with advanced diagnoses (Chambers et al, 2012), and groups of men at various disease stages (Badger et al, 2011;Hack et al, 2007;Northouse et al, 2007). Finally, interventions have been delivered according to treatment modality, including programs specific to men with prostate cancer who receive radiation (Kim et al, 2002), hormone therapies (Carmack Taylor et al, 2006;Culos-Reed et al, 2010;Templeton & Coates, 2004), or surgery (McCorkle et al, 2007;Molton et al, 2008;Parker et al, 2009;Weber et al, 2004;Zhang et al, 2006Zhang et al, , 2007.…”